Immun’Âge® Granted Japanese Patent Recognizing Activation of Nrf2, the Body’s Master Cellular Defense Pathway
Backed by more than 30 peer-reviewed human clinical studies supporting endogenous antioxidant activity, cellular resilience, and healthy aging LOS ANGELES, CA, UNITED STATES, January 27, 2026 /EINPresswire.com/ -- Osato Research Institute today …